Abbott (ABT) Declares $0.36 Quarterly Dividend; 1.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to Abbott (ABT) Declares $0.36 Quarterly Dividend; 1.6% Yield
June 15, 2020 7:06 AM EDT
Abbott (NYSE: ABT) announced today the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle® Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children ages 4 and older with diabetes. This is the only iCGM system with optional real-time alarms that measures glucose levels every minute, meeting the highest level of accuracy standards5 over 14 days, including superior day one1 accuracy compared to the other iCGM and excellent accuracy and alarm performance at low end glucose levels.6 With a 14-day wear time, the FreeStyle Libre 2 system is the longest-lasting,... More
June 11, 2020 2:05 AM EDT
By Francesco Guarascio
BRUSSELS (Reuters) - The market for COVID-19 antibody tests is red-hot. It has ballooned in a matter of months as hundreds of products flood the world for people who want to find out whether they've already had the virus.
The problem is, some of them don't work properly.
As a result, European authorities aim to tighten regulation of the new sector, to weed out tests that give consistently inaccurate results and crack down on companies that make false claims, three sources familiar with the plans told Reuters.
Much is on the... More
